RBC Capital Upgrades Chemours (CC) to Outperform; 'TT recovery and TSS strength'
Tweet Send to a Friend
RBC Capital analyst Arun Viswanathan upgraded Chemours (NYSE: CC) from Sector Perform to Outperform with a price target of $40.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
